Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 15.
Published in final edited form as: Mol Cell Endocrinol. 2013 May 16;379(0):19–29. doi: 10.1016/j.mce.2013.05.008

Mitochondrial and Skeletal Muscle Health with Advancing Age

Adam R Konopka 1, K Sreekumaran Nair 1
PMCID: PMC3788080  NIHMSID: NIHMS482433  PMID: 23684888

Abstract

With increasing age there is a temporal relationship between the decline of mitochondrial and skeletal muscle volume, quality and function (i.e., health). Reduced mitochondrial mRNA expression, protein abundance, and protein synthesis rates appear to promote the decline of mitochondrial protein quality and function. Decreased mitochondrial function is suspected to impede energy demanding processes such as skeletal muscle protein turnover, which is critical for maintaining protein quality and thus skeletal muscle health with advancing age. The focus of this review was to discuss promising human physiological systems underpinning the decline of mitochondrial and skeletal muscle health with advancing age while highlighting therapeutic strategies such as aerobic exercise and caloric restriction for combating age-related functional impairments.

1.0 Introduction

Reports of skeletal muscle atrophy that accompany advancing age (i.e., sarcopenia) and the associated reductions in skeletal muscle function and quality have been observed for several decades (Critchley 1931, Rosenberg 1989, Rosenberg 1997). Recently, panels of leading scientists and physicians associated with large-scale epidemiological studies have created specific, objective criteria based on lean tissue mass and functional capacity to improve the diagnosis and treatment of sarcopenia (Delmonico et al. 2007, Fielding et al. 2011, Goodpaster et al. 2006, Morley et al. 2011, Newman et al. 2003). Human aging starts after the third decade and the progression of skeletal muscle atrophy with age is a slow process (~1% per year), but accelerates as humans approach 80 years of age (Baumgartner et al. 1998). With expansion in human lifespan, the elevated rate of muscle loss becomes more problematic since skeletal muscle is critical for functionality and substrate metabolism. When the substrate reservoir deteriorates with age, the associated cardiometabolic disease states (i.e. insulin resistance, diabetes, cardiovascular disease, obesity) become more prevalent (Atlantis et al. 2009). Many studies have observed reduced skeletal muscle mass and infiltration of adipose tissue depots within or between skeletal muscle groups that are associated with reduced muscle function, insulin resistance and obesity (Delmonico et al. 2009, Goodpaster et al. 2005, Goodpaster et al. 2000). A key link between a reduction in skeletal muscle health and prevalence of metabolic disorders with advancing age may be related to impaired mitochondrial function. A reduction in mitochondrial abundance and function with age has been observed across various species (c elegans, drosphilla, mice, humans) and tissues (skin, nerve, brain, skeletal muscle). Moreover, perturbations in skeletal muscle mitochondrial energetics have been correlated with reduced aerobic capacity (Short et al. 2005a), walking capacity (Coen et al. 2012) and skeletal muscle function (Safdar et al. 2010) in older adults. The mechanisms of age-related changes in skeletal muscle are multifactorial but the purpose of this review is to highlight the apparent temporal and functional connection between the decline of mitochondrial and skeletal muscle health (Figure 1).

Figure 1. Reduced Mitochondrial and Skeletal Volume, Quality and Function with Sedentary Aging.

Figure 1

Sedentary aging is associated with the decline of mitochondrial and skeletal muscle volume, quality and function. The casual link between the loss of mitochondrial homeostasis and sarcopenia is unknown, however, both appear with advancing age and are associated with the loss of functional capacity and corresponding increases in comorbidities and annual healthcare costs. Exercise and physical activity are effective prescriptions to attenuate the negative consequences of sedentary aging illustrated in Figure 1.

2.0 Reduced mitochondrial content and function with age

Electron microscopic assessment of skeletal muscle biopsy samples revealed lower mitochondrial volume density in older adults (Conley et al. 2000). A decline in mitochondrial content, as represented by mitochondrial DNA copy number, has also been demonstrated in rodents (Barazzoni et al. 2000) and humans (Short et al. 2005a). These findings, coupled with investigations that observed reduced levels of mitochondrial protein synthesis (Rooyackers et al. 1996) and expression of proteins encoded by both mitochondrial and nuclear DNA (Lanza et al. 2008, Short et al. 2005a), are expected to alter mitochondrial function. Semi-quantitative analyses, such as immunoblotting or maximal enzyme activity, support the notion that aging skeletal muscle contains less abundance of enzymes in oxidative metabolism (i.e. Krebs Cycle, beta-oxidation) and/or proteins involved in the electron transport chain (ETC) (Cooper et al. 1992, Ghosh et al. 2011, Lanza et al. 2008, Rooyackers et al. 1996, Tonkonogi et al. 2003, Trounce et al. 1989). Collectively, reductions in mitochondrial proteins and volume may limit ATP production for energy demanding processes such as myocellular remodeling to maintain protein quality.

Advancements of in vitro and ex vivo measures of mitochondrial energetics have detected diminished capacity for basal (Petersen et al. 2003) and maximal (Conley et al. 2000, Kent-Braun and Ng 2000, Short et al. 2005a) mitochondrial ATP synthesis in older adults. When expressing the rate of mitochondrial ATP synthesis relative to mitochondrial content there remains a deficit in older adults suggesting that there is not only a reduction in mitochondrial protein content but also mitochondrial protein quality. These findings appear to be related to physical activity, as sedentary individuals had lower in vivo mitochondrial function compared to active individuals (Kent-Braun and Ng 2000, Larsen et al. 2012). It is important to acknowledge that in aging human skeletal muscle, findings of mitochondrial dysfunction are highly equivocal and the disparity between studies is not well discussed. In Table 1 we provide potential confounding variables related to the characteristics of research participants (column A) as well as the use of various measurements of mitochondrial abundance or function (column B). Key differences exist when interpreting data since each measurement in Table 1 assesses different constituents of mitochondrial abundance or function and each method presents key strengths and weaknesses as has been reviewed in detail previously (Lanza and Nair 2010, Perry et al. 2013). One difference could be comparisons between content or maximal activities of enzymes in the mitochondrial matrix (e.g., citrate synthase, βHAD) which are completely encoded by nuclear DNA versus proteins involved in oxidative phosphorylation (e.g., cytochrome c oxidase, NADH) that are encoded by both nuclear and mitochondrial genomes. Although analysis of maximal mitochondrial energetics in vivo (i.e., 31P-MRS) and ex vivo (i.e., high-resolution respirometry) are highly correlated (Lanza et al. 2011), subtle discrepancies still exist between different approaches for measuring mitochondrial function in vivo (basal vs. maximally stimulated) and ex vivo (ATP production vs. oxygen respiration; permeabilized fibers vs. isolated mitochondria). Also, sampling of human muscle tissue from various muscle groups consisting of different recruitment patterns and fiber type composition can create conflicting results between studies. These variables need to be recognized and addressed to properly assess the true age-related phenotype. Globally, when investigations utilize large sample sizes and rigorous control to avoid many of the confounding variables there appears to be an age-related decline in mitochondrial protein content, quality and function in the quadriceps femoris muscles. These data provide well-founded evidence for perturbations in mitochondrial health and connections to impaired functional capacity during sedentary aging.

Table 1.

Divergent subject characteristics and analytical techniques may contribute to discrepancies regarding aging mitochondrial health

The study of aging mitochondria presents inconsistent findings potentially associated with (A) variability in subject characteristics and (B) different analytical techniques to assess mitochondrial abundance or function within skeletal muscle. To examine the true age-related decline in mitochondrial health, descriptive characteristics listed in (A) need to be comprehensively discussed as these variables may each independently affect mitochondrial health. Moreover, the different analytical techniques listed in (B) are all highly but each approach studies different components of the mitochondria (i.e., citrate synthase enzyme activity vs. ex vivo ATP production in isolated mitochondria) and therefore may be a contributor to the equivocal findings between studies. Collectively, both subject characteristics and analytical techniques need to be considered when interpreting data describing the aging mitochondrial phenotype. References provided utilize or discuss the associated subject characteristic or analytical technique.

Aerobic training is an effective exercise prescription to stimulate markers of oxidative capacity as established in the 1960’s (Holloszy 1967), when it was revealed that aerobic exercise of sufficient intensity increased mitochondrial enzyme activity in animal models. Numerous other investigations have confirmed these results, however, few studies in humans have directly investigated if age influences exercise induced mitochondrial adaptations after the same exercise training program. From the few available studies, it appears that mitochondrial molecular regulation and protein content are increased after 12–16 weeks of exercise training, independent of age, suggesting older individuals (<80y) adapt favorably to exercise training (Ghosh et al. 2011, Short et al. 2003). However, the influence of various exercise training programs (i.e., aerobic vs. resistance vs. concurrent training) on mitochondrial and skeletal muscle function (ex vivo or in vivo) has yet to be determined and warrants investigation. Collectively, these data suggest that exercise can improve or prevent the loss of mitochondrial health during sedentary aging (Figure 2).

Figure 2. Mitochondrial Adaptations to Aerobic Exercise Training.

Figure 2

With contractile activity, elevated levels of metabolic byproducts (i.e., NAD, AMP, Ca++, ROS, etc.) provide a stimulus for increased molecular regulators of mitochondrial transcription, replication and dynamics (i.e, NAMPT, SIRT-1, PGC-1α, NRF-1, -2, TFAM, MFN-1, -2, FIS1, DRP1). Collectively, these alterations promote the increase in mitochondrial protein turnover allowing for the degradation of damaged proteins and de novo synthesis of new functional proteins. Overall, the elevated rate of mitochondrial protein turnover suggests an improvement in the quality of mitochondrial proteins for enhanced ATP production and lower reactive oxygen species (ROS) emission. Enhanced mitochondrial function may augment myocellular remodeling, skeletal muscle anabolism and functional capacity in older adults.

3.0 Molecular Regulation of Aging Mitochondria

The mitochondria consist of proteins encoded from both mitochondrial (mtDNA) and nuclear DNA (nDNA). Although mtDNA contains just 27 genes that encode 13 proteins (all within the electron transport chain), 2 ribosomal and 22 translational RNA, proper organelle biogenesis and function require input from both genomes. Several transcription factors and molecular regulators have been highlighted in orchestrating mitochondrial biogenesis and substrate metabolism. The exploration of the molecular regulation of mitochondria has received much attention to gain insight into the etiology of aging mitochondria and associated disease conditions. The family of sirtuins, NAMPT, PGC-1α, NRF 1, NRF 2, TFAM as well as metabolite sensors such as AMPK, CAMK and calcium flux play an integral role in maintaining mitochondrial homeostasis as illustrated in Figure 2.

3.1 Sirtuins

The Sirtuin family (SIRT 1–7) is an NAD-dependent histone/protein deacetylase that interacts with transcription factors and cofactors influencing many metabolic pathways (for review see (Guarente 2011, Gurd 2011, Westphal et al. 2007, White and Schenk 2012)). SIRT1 is the most well described Sirtuin due to the favorable impact on targets associated with cellular growth, chromatin remodeling, substrate metabolism and mitochondrial biogenesis. Specifically, the capability of SIRT1 to deacetylate PGC-1α, relaying signal transduction for mitochondrial biogenesis, improved substrate utilization and insulin action is particularly relevant in improving the aging phenotype. In addition, SIRT3, which is localized to the mitochondria, is associated with mitochondrial efficiency and ROS production. SIRT3 knockout animals demonstrate hyperacetylation interfering with proper mRNA transcription, elevated levels of ROS and concomitant reduction in ATP synthesis much like many aging models (Ahn et al. 2008, Kim et al. 2010). These data are substantiated from mechanistic studies displaying the ability of SIRT3 to deacetylate and activate MnSOD and glutathione-scavenging pathway enzymes to protect from reactive oxygen species (ROS) during SIRT3 overexpression and caloric restriction (Someya et al. 2010). Elevated ROS emissions from the mitochondria have been implicated in the progression of mitochondrial dysfunction and development of insulin resistance (Fisher-Wellman and Neufer 2012). Therefore, SIRT 1 and 3 may play a role in mitochondrial health, insulin action and functional capacity with advancing age.

Sedentary older adults contain less SIRT3 content, however, it appears those who perform vigorous endurance exercise are capable of maintaining SIRT3 compared to there younger counterparts (Lanza et al. 2008). Indeed, SIRT3 abundance and activity increase after contractile activity and may be a potential mechanism for improved ATP synthesis, ROS production and insulin action (Gurd et al. 2012). Exploring the upstream regulation of the sirtuin family is essential to fully appreciate how various interventions (i.e., exercise, caloric restriction, medications) mediate the intracellular signaling pathways associated with mitochondrial biogenesis and protein quality.

3.2 Peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α

In aging human skeletal muscle, there have been observations of either reduced or unaltered levels of PGC-1α (Lanza et al. 2008, Ling et al. 2004). Since PGC-1α is considered the master regulator of mitochondrial biogenesis, lower levels may partially reduce downstream transcription factors as well as mitochondrial content and function. This hypothesis is supported by a diminished capacity to stimulate mitochondrial biogenesis or maintain mitochondrial content during active-aging in animals with genetically altered PGC-1α (Leick et al. 2010). Additionally, animals with overexpressed PGC-1α demonstrate mitochondrial biogenesis and reversal of many age-related diseases including sarcopenia (Wenz 2011, Wenz et al. 2009). Acute and chronic aerobic exercise increase PGC-1α mRNA expression similarly in young and old individuals (Cobley et al. 2012, Short et al. 2003). Older people who have maintained a high level of aerobic exercise for several years had greater protein expression of PGC-1α than sedentary young people yet failed to achieve similar levels as younger people who also maintained high levels of aerobic training (Lanza et al. 2008) suggesting that exercise can mitigate some age-related losses but cannot fully protect the molecular regulation of mitochondrial biogenesis. Skeletal muscle biopsy samples obtained from a unique group of adults over 80y of age revealed that those who engaged in vigorous life-long endurance exercise have greater PGC-1α mRNA expression compared to their healthy counterparts who performed normal activities of daily living (Trappe et al. 2012). Although PGC-1α is not obligatory for exercise induced mitochondrial biogenesis (Leick et al. 2008) it still appears to be a valuable component in the effects of exercise on skeletal muscle and metabolic health with advancing age. Interestingly, an isoform of PGC-1α (PGC-1α4) has been comprehensively demonstrated to be involved in skeletal muscle hypertrophy in vitro and in vivo (Ruas et al. 2012). PGC-1α4 appears to be the primary isoform associated with skeletal muscle growth through the stimulation of IGF-1 and suppression of myostatin, MuRF-1 and Atrogin-1 mRNA expression. Interestingly, previous studies have demonstrated that aerobic (Konopka et al. 2010) and resistance (Kim et al. 2005, Roth et al. 2003, Ryan et al. 2011, Williamson et al. 2010) exercise training reduced catabolic mRNA expression (i.e., FOXO3a, MuRF-1, Atrogin-1 and/or myostatin) with concomitant skeletal muscle hypertrophy. These adaptations could be associated with elevated levels of PGC-1α4 as recently revealed but further examination is needed. Elevated PGC-1α isoforms with exercise training in sedentary humans occurs concomitantly with increased mitochondrial protein content, mixed muscle protein synthesis, skeletal muscle hypertrophy and aerobic capacity (Harber et al. 2009b, Harber et al. 2012, Ruas et al. 2012, Short et al. 2004, Short et al. 2003). Collectively, these investigations highlight the advantages of PGC-1α in promoting a healthy aging, skeletal muscle phenotype.

3.3 Mitochondrial transcription factor A (TFAM) and Nuclear respiratory factor (NRF)-1 & -2

Recent research has revealed that PGC-1α relocates to both the mitochondrial and nuclear compartments after a physiological stimulus, such as aerobic exercise, to coordinate mitochondrial biogenesis from both nuclear and mitochondrial genomes (Safdar et al. 2011). Most reports describe PGC-1α by directly acting on NRF-1 & -2 within the nucleus to stimulate increased levels of mitochondrial transcription factor A (TFAM) followed by import into the mitochondria. However, it appears that PGC-1α can also act independently on NRF-1 and TFAM by binding to the NRF-1 promoter region within the nucleus as well as being complexed with TFAM and the mtDNA D-loop region within the mitochondrial matrix to transcriptionally coordinate nuclear-and mitochondrial-encoded proteins. These studies established an updated paradigm into the mechanisms of how PGC-1α orchestrates mitochondrial biogenesis through key transcriptional regulators NRF-1 and TFAM.

In addition to binding to mtDNA for transcriptional induction of mitochondrial biogenesis, TFAM also has a strong affinity for mtDNA to stabilize and package the genome into a nucleoid structure (for detailed review see (Campbell et al. 2012)). Stabilizing mtDNA appears to be a protective mechanism to prevent damage and/or loss of mtDNA copy number as observed in aging skeletal muscle (Short et al. 2005a). However, in aging brain tissue, TFAM was elevated with a concomitant reduction in mtDNA most likely due to impaired binding of TFAM to mtDNA regions (Picca et al. 2012). Mitochondrial protein turnover via Lon protease, discussed in the next section, is thought to regulate the TFAM:mtDNA ratio to enhance stability and transcription (Matsushima et al. 2010). Exercise is known to increase TFAM and mtDNA number highlighting the potential for improved TFAM-mtDNA binding with chronic exercise. The regulation of transcription, translation and mitochondrial biogenesis is still not completely understood and further research is warranted.

4.0 Skeletal Muscle and Mitochondrial Protein Turnover

In addition to transcriptional regulation, the accretion of new proteins and degradation of older proteins may have a large impact on mitochondrial morphology and function. It is important to note that changes in mitochondrial protein turnover may not always be reflected by expression of mitochondrial proteins. For example, when the rates of de novo synthesized proteins are elevated while being matched by the breakdown of older irreversibly modified proteins, no apparent changes in protein abundance can be detected. More importantly, elevated protein turnover (i.e., the replacement of modified and presumably dysfunctional proteins by de novo synthesized proteins) may be a strategic mechanism to maintain mitochondrial protein quality and function (Figure 3). This notion is supported by a study demonstrating that life long caloric restricted mice maintained mitochondrial function with age but did not increase mitochondrial abundance (Lanza et al. 2012). Instead of mitochondrial proliferation, caloric restricted mice improved mitochondrial protein quality compared to their ad libitum fed counterparts. These concepts strongly emphasize the need to measure mitochondrial protein synthesis and breakdown as a process to increase or maintain mitochondrial function with age.

Figure 3. Effect of Aging and Exercise on Protein Damage and Quality.

Figure 3

With aging, excess reactive oxygen species (ROS) are produced from mitochondria with a concomitant reduction of protein degradation and synthesis (i.e., protein turnover). The combination of elevated ROS and reduced protein turnover can lead to the accumulation of damage to proteins resulting in reduced protein quality and function. We hypothesis that exercise training can attenuate age-related production of ROS and stimulate protein turnover, in turn, degrading oxidatively damaged proteins and replacing with newly synthesized, functional proteins.

4.1 Mitochondrial Protein Synthesis

Infusion of stable isotope tracer into young and older adults demonstrated decreased rates of in vivo mitochondrial protein synthesis rate in skeletal muscle of older adults and is accompanied with diminished mitochondrial enzyme activity (Rooyackers et al. 1996). These data provide a feasible connection between the decreased ability to replace mitochondrial proteins in aging skeletal muscle leading to mitochondrial enzymatic dysfunction. Furthermore, mitochondrial protein synthesis rates are initially reduced during middle age, which may be a precursor to the progressive loss of mitochondrial protein abundance and function with older age. Other investigations have confirmed the deficit in mitochondrial protein synthesis rate in older adults (Guillet et al. 2004) while advancements of innovative methodology has allowed for the analysis of individual mitochondrial protein synthesis rates to elucidate specific proteins that may participate in the etiology of aging mitochondrial dysfunction (Jaleel et al. 2008, Lanza et al. 2012).

While increased mitochondrial content is an established adaptation of aerobic exercise, the impact of exercise on mitochondrial protein turnover is not well characterized. One group has demonstrated that acute and chronic aerobic exercise increases mitochondrial protein synthesis rates in younger individuals (Wilkinson et al. 2008). However, the effects of exercise on aging mitochondrial protein turnover have not yet been examined. Due to the clear associations with mitochondrial biogenesis and function, studies are needed to comprehensively elucidate the impact of exercise training on overcoming diminished mitochondrial protein synthesis in aging humans.

4.2 Mitochondrial Protein Degradation

Due to difficulties of properly assessing protein degradation in human skeletal muscle, the literature is equivocal and largely unknown. However, global assessments indicate whole-body protein degradation is reduced in older adults (Balagopal et al. 1997, Henderson et al. 2009). These data, in conjunction with lower rates of mixed muscle (Short et al. 2004), myosin heavy chain (Balagopal et al. 1997) and mitochondrial protein synthesis (Rooyackers et al. 1996), suggest that a low protein turnover in older adults may allow for a reduction in protein quality by accumulation of modified proteins in organelles (i.e., mitochondria) and tissues (i.e., skeletal muscle) creating further dysfunction with age (Figure 3). It is important to note that different skeletal muscle subfractions (Balagopal et al. 1997, Rooyackers et al. 1996, Short et al. 2004, Trappe et al. 2004), fiber types (Dickinson et al. 2010), and individual proteins (Jaleel et al. 2008) have diverse rates of protein turnover and warrant further examination as a component of the age-related loss of mitochondrial and skeletal muscle health. Currently, methods to determine skeletal muscle and mitochondrial protein degradation are not well developed. These key limitations highlight the need for advancement of novel techniques to properly assess protein degradation and propel our understanding of human skeletal muscle biology.

4.2.1 Mitochondrial Dynamics

One particular area of interest regarding mitochondrial turnover is the collaboration of mitochondrial fusion, fission and autophagy (i.e. mitochondrial dynamics) to regulate organelle morphology. Mitochondrial fusion is the combination of outer mitochondrial membrane and subsequent mixing of intramitochondrial components to dilute any damaged mitochondrial DNA or proteins. Additionally, mitofusion proteins also assist in molding the inner mitochondrial membrane cristae, making the collective purpose of mitofusion to prevent the dissipation of mitochondrial membrane potential and thus ATP synthesis. Investigations utilizing animal knockout models of mitofusion proteins have demonstrated diminished mitochondrial function and biogenesis as well as muscle atrophy (Chen et al. 2010).

Conversely, when fusion is no longer possible due to the loss of mitochondrial membrane integrity, fission is responsible for the fragmentation and excision of any altered or damaged mitochondrial components that are subsequently degraded by mitochondrial specific autophagy (i.e. mitophagy) (Seo et al. 2010). Mitochondrial dynamics are essential to maintain normal mitochondrial metabolism, morphology and homeostasis in highly oxidative tissues such as skeletal muscle (Masiero et al. 2009). Therefore, from recent research revealing that select mitofusion and mitofission markers (i.e., mRNA) are reduced in aging human skeletal muscle (Crane et al. 2010), we can infer that mitochondrial turnover is compromised which could partially mediate age-related mitochondrial dysfunction and impaired skeletal muscle health. Interestingly, markers of mitochondrial dynamics are elevated with acute exercise in young individuals (Cartoni et al. 2005, Slivka et al. 2012) suggesting that exercise can increase mitochondrial turnover, which may lead to favorable mitochondrial functional improvements.

4.2.2 Proteolytic Pathways

The autophagy-lysosome and ubiquitin-proteasome (UPP) pathways are two major systems that mediate protein degradation and maintain cellular homeostasis. Autophagy appears to be associated with more bulk protein degradation of large areas and/or organelles, such as mitochondria, that are encapsulated by the phagophore, fused with the lysosome and subsequently broken down to amino acids (Figure 2). Conversely, the UPP is responsible for marking select proteins that are damaged or misfolded with an ubiquitin tail for degradation via the proteasome. Recent research suggests that the UPP may interact with autophagy by assisting the regulation of mitochondrial dynamics and disposal of damaged mitochondrial proteins. Additionally, evidence indicates the role of UPP in regulating cellular homeostasis may be distinct in various skeletal muscle organelles or sub-fractions (i.e. sarcoplasmic, myofibrillar, mitochondrial).

One mitochondrial quality control mechanism is the ATP-stimulated Lon protease located in the mitochondrial matrix (Figure 2). Lon protease is believed to be an integral factor in the degradation of oxidatively damaged mitochondrial proteins (Bota and Davies 2002). In aging models, Lon protease is reduced and therefore hypothesized to play a role in the development of mitochondrial dysfunction in older tissues (Bota et al. 2002, Lee et al. 1999). Another mitochondrial quality control pathway is autophagy, as evidenced by the maintenance of mitochondrial function in the liver of older transgenic mice compared to wild type mice (Zhang and Cuervo 2008). Similarly, overexpression of autophagy proteins in human umbilical vein endothelial cells appears to remove damaged mitochondrial proteins when challenged with reactive oxygen species in vitro (Mai et al. 2012). Data in human skeletal muscle are limited but recent studies have observed no measurable differences between young and older individuals at the mRNA level for markers of UPP or autophagy (Fry et al. 2012a). It is interesting to note that mRNA of UPP was elevated and/or autophagy reduced in humans undergoing accelerated atrophy (i.e. >80y old (Raue et al. 2007, Williamson et al. 2010), para- (Fry et al. 2012b) and hemiplegia (von Walden et al. 2012)). Development of dynamic assays to measure protein degradation specific to the mitochondrial and myofibrillar proteins are needed to provide a direct functional connection to protein metabolism and age.

Acute aerobic exercise appears to increase mRNA expression of proteolytic pathways within mixed muscle homogenates (Harber et al. 2009a, Harber et al. 2010, Louis et al. 2007, Pasiakos et al. 2010). These data suggest that the molecular induction of protein degradation is elevated by acute exercise, most likely providing amino acids for de novo synthesis (Balagopal et al. 2001) and myocellular remodeling that leads to improved contractile function after chronic exercise (Harber et al. 2004, Harber et al. 2009b, Harber et al. 2012, Trappe et al. 2001) Interestingly, exercise training programs that improve skeletal muscle size and function in adults (<80 y) observed reductions in proteolytic markers (Konopka et al. 2010, Williamson et al. 2010), most likely shifting protein balance in favor of skeletal muscle protein accretion. Collectively, these data reveal the differences between transient alterations and chronic adaptations in proteolytic machinery highlighting the need for additional investigations examining protein turnover to substantiate the link to myocellular and mitochondrial function after acute and chronic exercise.

5.0 Insufficient Antioxidant Capacity and Oxidative Damage

Reactive oxygen species (ROS) are molecules containing one or more unpaired electrons mainly produced from complex I and III in the ETC. These byproducts are normally detoxified by antioxidants (e.g. MnSOD, CuZnSOD, catalase) but when they are generated in excess of antioxidant capacity they can irreversibly modify (i.e. damage) lipids, proteins, and DNA. Due to inconsistent findings on the antioxidant capacity in older adults (Ghosh et al. 2011, Gianni et al. 2004, Leeuwenburgh et al. 1994, Pansarasa et al. 2000) there is a strong need to determine antioxidant capacity at the systemic, skeletal muscle and mitochondrial compartments to fully identify where these defense mechanisms fail and where development of therapies should be focused to ameliorate oxidant damage and cellular dysfunction with age.

Damage to mtDNA is suspected to occur easily due to the proximity near the ETC and lack of protection by histones. The combined effects of reduced protein turnover and excess ROS emission create an environment conducive in aging skeletal muscle for the accumulation of oxidatively damaged mtDNA and contractile proteins (Figure 3). Accrual of mtDNA damage may then allow production of dysfunctional proteins within the ETC, further exaggerating ROS emission and oxidative damage. This scenario is considered the mitochondrial theory of aging first hypothesized by Harman in 1972 (Harman 1972). However, it is important to note that the appearance of mtDNA deletion/mutations in human skeletal muscle is relatively small, with data indicating that mtDNA deletions may reach levels of physiological significance only in adults greater than 80y old (Bua et al. 2006, Chabi et al. 2005, Kopsidas et al. 1998, Kovalenko et al. 1997) although many age-related changes including sarcopenia begin much earlier. When mtDNA deletions are present in single muscle fibers they appear red and ragged, leading to fiber atrophy and eventually fiber loss (Bua et al. 2006). Moreover, mtDNA deletions and fiber atrophy are more prevalent in fast MHC II fibers, which is consistent with age-related loss of fast fiber composition and contractile properties. The pattern of mtDNA deletion mutations, fiber atrophy and fiber loss provides a clear relationship between mitochondria and skeletal muscle atrophy.

Data from mitochondrial bioenergetics supports the role of altered mitochondrial membrane potential in mediating excess levels of oxidant production (Fisher-Wellman and Neufer 2012). The concept is based on redox biology of mitochondria where over nutrition (i.e. increased supply) and/or reduced physical activity (i.e. reduced demand) appears to create a buildup of protons thus creating a high membrane potential that could cause a cessation of electron flow through the ETC. The disruption in electron flow is thought to increase oxidant production by acting as a release valve to dissipate the elevated membrane potential. Any mechanism to allow protons to flow back to the mitochondrial matrix (ATP synthesis or uncoupling) will also help relieve membrane potential and therefore oxidant production. This notion is supported by findings that life long caloric restriction attenuates H2O2 emission by eliminating excess energy intake (i.e. supply) and mitigates the accumulation of post-translational modifications, especially oxidation and deamidation, while concomitantly maintaining mitochondrial energetics with age (Lanza et al. 2012). These novel data are available due to recent advancements where proteome quality can be assessed by the evaluation of post-translational modifications using tandem mass spectrometry. Not only can this innovative approach comprehensively detect global protein modifications, it can also determine which amino acid residues are most commonly modified. Implementing proteome analysis of post-translational modifications may provide a platform to develop and test innovative strategies to reduce the accumulation of modified and functionally impaired proteins.

In addition to caloric restriction, physical activity levels play a strong role in modulating skeletal muscle quality as sedentary older individuals have a noticeable decline in antioxidant capacity with concomitant oxidative damage compared to age-matched active individuals (Safdar et al. 2010). Oxidative modifications can affect action potential propagation, ETC complexes, calcium transport/regulation, and myosin and actin interaction; collectively reducing skeletal muscle function in rodent models (Fulle et al. 2004, Rossi et al. 2008). In a unique model of muscle dysfunction, individuals with chronic obstructive pulmonary disease were characterized with increased oxidative damage that was negatively correlated with aerobic capacity and isometric skeletal muscle force production (Barreiro et al. 2009). These data are supported in older adults as elevated oxidative damage has been correlated with diminished functional capacity (Howard et al. 2007, Semba et al. 2007a) and increased risk of mortality (Semba et al. 2007b). Therefore, there are implications that excess ROS may be an underlying characteristic in the progression of muscle atrophy by introducing oxidative damage that can negatively affect the functional capabilities of older adults.

6.0 A role for epigenetic regulation of mitochondrial and contractile proteins

The age-related decline in transcription (i.e., mRNA expression) and translation (i.e., protein synthesis) are apparent in the loss of mitochondrial and contractile protein quality. The underlying mechanisms for reduced transcription include epigenetics, which also has a responsibility in shaping the aging phenotype in response to environmental influences like physical activity and diet. Common epigenetic mechanisms are modifications to DNA and/or histones (i.e., acetylation, methylation). Changes in the methylation and acetylation status can modify chromatin structure, which in turn alters the binding capability of transcription factors to create mRNA (Figure 4). Epigenomic research has large implications in improving our understanding of the aging mitochondrial and contractile dysfunction but is currently at its nascent stages.

Figure 4. Epigenetic Regulation of Mitochondrial and Contractile Proteins.

Figure 4

Epigenetic control of mitochondrial and contractile proteins may improve our knowledge on the development of the aging phenotype. During sedentary aging, chromatin is condensed by altered levels of acetylation and/or methylation that prevent binding of transcription factors. With exercise, modifications of histones (indirect modification) and/or DNA (direct modification) may allow an open chromatin structure where transcription factors can bind to DNA promoter regions for mRNA transcription to occur. The shifts between condensed chromatin during sedentary aging and open chromatin with exercise are partially mediated by DNA and histone modifying enzymes: DNA methyl transfereases (DNMT), histone acetyl transferases (HATs), histone methyl transferases (HMTs), histone deacetylases (HDACs) and histone demethylases (HDMs). The schematic was adopted from Zwetsloot et al. (Zwetsloot et al. 2009) and altered to reflect our perspective on epigenetic control of mitochondrial and contractile protein quality.

It appears with older age there is an increase in DNA methylation of promoter regions for genes involved in oxidative phosphorylation and the level of DNA methylation is inversely correlated with gene expression (Ling et al. 2007, Ronn et al. 2008). These data suggest that altered methylation could be involved in reduced mitochondrial mRNA expression and protein synthesis observed in older adults. More expansive investigation is necessary to determine key promoter regions that may be differentially methylated. Furthermore, alterations to mitochondrial function may provide feedback to influence epigenetic regulation of mitochondrial and nuclear genome.

In addition to mitochondrial regulation, epigenetic alterations also appear to influence key skeletal muscle contractile proteins. The balance between histone acetylation and deacetylation changes in concordance with shifts in myosin heavy chain composition during unloading (Pandorf et al. 2009). This is of particular interest when exploring the mechanisms mediating changes in MHC composition of aging skeletal muscle that occurs with concomitant reductions in size and contractile performance of fast, MHC IIa fibers (Lexell et al. 1983, Trappe et al. 2003). Fast myosin light chain isoforms, thought to influence contractile function, were found to be negatively correlated with promoter methylation (Donoghue et al. 1991) suggesting that methylation may inhibit fast fiber performance as observed in older adults.

Currently, exercise seems to be one of the most impactful stimuli that alters skeletal muscle physiology (i.e., MHC and mitochondrial protein abundance and function (Balagopal et al. 1997, Coggan et al. 1992, Ghosh et al. 2011, Harber et al. 2009b, Harber et al. 2012, Konopka et al. 2011, Short et al. 2005b, Short et al. 2003)) and serves as a countermeasure to many negative consequences of sedentary aging. However, the effects of exercise and age on epigenetic regulation of mRNA expression and skeletal muscle adaptations are relatively unknown. Acute aerobic exercise can induce histone modifications that may mediate chromatin remodeling and disassociations with transcription factors implicated in substrate metabolism (McGee et al. 2009, McGee and Hargreaves 2004). Moreover, acute and chronic contractile activity increased SIRT1 deacylate activity within the nucleus which is most likely related to increased PGC-1α mRNA (Gurd 2011, Gurd et al. 2011). An eloquent study (Barres et al. 2012) recently revealed that acute aerobic exercise of sufficient intensity can alter global and promoter specific methylation leading to changes in mRNA expression related to mitochondrial and substrate regulation in young adults. More investigations like Barres et al. are needed to clearly determine the influence of age and chronic exercise on the epigenetic regulation of global and specific promoter regions related to mitochondrial (e.g, PGC-1α, SIRT1, TFAM) and contractile proteins (e.g. MHC, MLC, actin, troponin) (Figure 4). Discovering the epigenetic modulation of skeletal muscle has vast potential to facilitate the development of novel therapies to improve protein quality with age.

Perspectives on Aging Skeletal Muscle and Mitochondrial Health

The common loss of mitochondrial and skeletal muscle volume, function and quality is an attractive relationship to help explain the comorbidities associated with aging. More research is needed to confirm that the loss of mitochondria health undermines sarcopenia, especially due to the variability within human studies. Some inconsistency seems to be related to different physical activity and lifestyle choices between subjects. This variability may partially be explained by the implementation of epigenetic research to gain comprehensive insight into the molecular regulation of aging in sedentary and physically active individuals. Exercise training and physical activity remain effective strategies to attenuate the development of mitochondrial and skeletal muscle dysfunction but many questions remain unanswered. Moreover, the role of chronic caloric restriction requires controlled studies that balance the potential adverse effects due to loss of lean mass and energy balance versus beneficial effects associated with reduced oxidative damage to proteins and DNA. In many aging populations, adherence or ability to participate in exercise is limited due to orthopedic or disease limitations (i.e. heart failure, chronic obstructive pulmonary disease) which warrants exploration of other therapies (i.e., caloric restriction, diet composition, non-traditional exercise, etc.) to help prevent the negative health consequences and elevated healthcare costs related to sedentary aging.

Highlights.

  1. A temporal and functional connection exists between the decline of mitochondrial and skeletal muscle health with age.

  2. Lower mitochondrial mRNA expression, protein abundance and synthesis rates promote the decline of mitochondrial function.

  3. Reduced mitochondrial function may impede energy demanding processes such as protein turnover.

  4. Decreased protein turnover results in lower protein quality and function in aging skeletal muscle.

Acknowledgments

The authors are grateful for the skillful and diligent assistance of Katherine Klaus, Dawn Morse, Jill Schimke, Maureen Bigelow, Daniel Jakaitis, Roberta Soderberg, Beth Will, Deborah Sheldon and Melissa Aakre. This research was supported by National Institutes of Health grants UL1-RR-024150-01 and AG09531, R01-DK41973 (KSN) and T32 DK007352-34 (ARK). Additional support was provided by Mayo Foundation and the Murdock-Dole Professorship (KSN).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A. 2008;105:14447–52. doi: 10.1073/pnas.0803790105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aiken J, Bua E, Cao Z, Lopez M, Wanagat J, McKenzie D, McKiernan S. Mitochondrial DNA deletion mutations and sarcopenia. 2002;959:412–23. doi: 10.1111/j.1749-6632.2002.tb02111.x. [DOI] [PubMed] [Google Scholar]
  3. Amara CE, Shankland EG, Jubrias SA, Marcinek DJ, Kushmerick MJ, Conley KE. Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo. 2007;104:1057–62. doi: 10.1073/pnas.0610131104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Atlantis E, Martin SA, Haren MT, Taylor AW, Wittert GA. Inverse associations between muscle mass, strength, and the metabolic syndrome. Metabolism. 2009;58:1013–22. doi: 10.1016/j.metabol.2009.02.027. [DOI] [PubMed] [Google Scholar]
  5. Balagopal P, Rooyackers OE, Adey DB, Ades PA, Nair KS. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol. 1997;273:E790–800. doi: 10.1152/ajpendo.1997.273.4.E790. [DOI] [PubMed] [Google Scholar]
  6. Balagopal P, Schimke JC, Ades P, Adey D, Nair KS. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab. 2001;280:E203–8. doi: 10.1152/ajpendo.2001.280.2.E203. [DOI] [PubMed] [Google Scholar]
  7. Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem. 2000;275:3343–7. doi: 10.1074/jbc.275.5.3343. [DOI] [PubMed] [Google Scholar]
  8. Barreiro E, Rabinovich R, Marin-Corral J, Barbera JA, Gea J, Roca J. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax. 2009;64:13–9. doi: 10.1136/thx.2008.105163. [DOI] [PubMed] [Google Scholar]
  9. Barres R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, Caidahl K, Krook A, O’Gorman DJ, Zierath JR. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012;15:405–11. doi: 10.1016/j.cmet.2012.01.001. [DOI] [PubMed] [Google Scholar]
  10. Barrientos A, Casademont J, Rotig A, Miro O, Urbano-Marquez A, Rustin P, Cardellach F. Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem Biophys Res Commun. 1996;229:536–9. doi: 10.1006/bbrc.1996.1839. [DOI] [PubMed] [Google Scholar]
  11. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63. doi: 10.1093/oxfordjournals.aje.a009520. [DOI] [PubMed] [Google Scholar]
  12. Boffoli D, Scacco SC, Vergari R, Solarino G, Santacroce G, Papa S. Decline with age of the respiratory chain activity in human skeletal muscle. 1994;1226:73–82. doi: 10.1016/0925-4439(94)90061-2. [DOI] [PubMed] [Google Scholar]
  13. Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol. 2002;4:674–80. doi: 10.1038/ncb836. [DOI] [PubMed] [Google Scholar]
  14. Bota DA, Van Remmen H, Davies KJ. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett. 2002;532:103–6. doi: 10.1016/s0014-5793(02)03638-4. [DOI] [PubMed] [Google Scholar]
  15. Bua E, Johnson J, Herbst A, Delong B, McKenzie D, Salamat S, Aiken JM. Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am J Hum Genet. 2006;79:469–80. doi: 10.1086/507132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Campbell CT, Kolesar JE, Kaufman BA. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim Biophys Acta. 2012;1819:921–9. doi: 10.1016/j.bbagrm.2012.03.002. [DOI] [PubMed] [Google Scholar]
  17. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Deriaz O, Zorzano A, Gobelet C, Kralli A, Russell AP. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005;567:349–58. doi: 10.1113/jphysiol.2005.092031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chabi B, Mousson de Camaret B, Chevrollier A, Boisgard S, Stepien G. Random mtDNA deletions and functional consequence in aged human skeletal muscle. Biochem Biophys Res Commun. 2005;332:542–9. doi: 10.1016/j.bbrc.2005.04.153. [DOI] [PubMed] [Google Scholar]
  19. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, Chan DC. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 2010;141:280–9. doi: 10.1016/j.cell.2010.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chretien D, Gallego J, Barrientos A, Casademont J, Cardellach F, Munnich A, Rotig A, Rustin P. Biochemical parameters for the diagnosis of mitochondrial respiratory chain deficiency in humans, and their lack of age-related changes. Biochem J. 1998;329 (Pt 2):249–54. doi: 10.1042/bj3290249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cobley JN, Bartlett JD, Kayani A, Murray SW, Louhelainen J, Donovan T, Waldron S, Gregson W, Burniston JG, Morton JP, Close GL. PGC-1alpha transcriptional response and mitochondrial adaptation to acute exercise is maintained in skeletal muscle of sedentary elderly males. Biogerontology. 2012;13:621–31. doi: 10.1007/s10522-012-9408-1. [DOI] [PubMed] [Google Scholar]
  22. Coen PM, Jubrias SA, Distefano G, Amati F, Mackey DC, Glynn NW, Manini TM, Wohlgemuth SE, Leeuwenburgh C, Cummings SR, Newman AB, Ferrucci L, Toledo FG, Shankland E, Conley KE, Goodpaster BH. Skeletal Muscle Mitochondrial Energetics Are Associated With Maximal Aerobic Capacity and Walking Speed in Older Adults. J Gerontol A Biol Sci Med Sci. 2012 doi: 10.1093/gerona/gls196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth PM, Holloszy JO. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. J Appl Physiol. 1992;72:1780–6. doi: 10.1152/jappl.1992.72.5.1780. [DOI] [PubMed] [Google Scholar]
  24. Conley KE, Jubrias SA, Esselman PC. Oxidative capacity and ageing in human muscle. J Physiol. 2000;526(Pt 1):203–10. doi: 10.1111/j.1469-7793.2000.t01-1-00203.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Conley KE, Jubrias SA, Amara CE, Marcinek DJ. Mitochondrial dysfunction: impact on exercise performance and cellular aging. 2007;35:43–9. doi: 10.1249/JES.0b013e31803e88e9. [DOI] [PubMed] [Google Scholar]
  26. Cooper JM, Mann VM, Schapira AH. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J Neurol Sci. 1992;113:91–8. doi: 10.1016/0022-510x(92)90270-u. [DOI] [PubMed] [Google Scholar]
  27. Crane JD, Devries MC, Safdar A, Hamadeh MJ, Tarnopolsky MA. The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure. J Gerontol A Biol Sci Med Sci. 2010;65:119–28. doi: 10.1093/gerona/glp179. [DOI] [PubMed] [Google Scholar]
  28. Critchley M. THE NEUROLOGY OF OLD AGE. Lancet. 1931;1:1221–1231. [Google Scholar]
  29. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, Tylavsky FA, Newman AB. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–74. doi: 10.1111/j.1532-5415.2007.01140.x. [DOI] [PubMed] [Google Scholar]
  30. Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90:1579–85. doi: 10.3945/ajcn.2009.28047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dickinson JM, Lee JD, Sullivan BE, Harber MP, Trappe SW, Trappe TA. A new method to study in vivo protein synthesis in slow- and fast-twitch muscle fibers and initial measurements in humans. J Appl Physiol. 2010;108:1410–6. doi: 10.1152/japplphysiol.00905.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Donoghue MJ, Alvarez JD, Merlie JP, Sanes JR. Fiber type- and position-dependent expression of a myosin light chain-CAT transgene detected with a novel histochemical stain for CAT. J Cell Biol. 1991;115:423–34. doi: 10.1083/jcb.115.2.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249–56. doi: 10.1016/j.jamda.2011.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Fisher-Wellman KH, Neufer PD. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol Metab. 2012;23:142–53. doi: 10.1016/j.tem.2011.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Fry CS, Drummond MJ, Glynn EL, Dickinson JM, Gundermann DM, Timmerman KL, Walker DK, Volpi E, Rasmussen BB. Skeletal Muscle Autophagy and Protein Breakdown Following Resistance Exercise are Similar in Younger and Older Adults. J Gerontol A Biol Sci Med Sci. 2012a doi: 10.1093/gerona/gls209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Fry CS, Drummond MJ, Lujan HL, Dicarlo SE, Rasmussen BB. Paraplegia increases skeletal muscle autophagy. Muscle Nerve. 2012b;46:793–8. doi: 10.1002/mus.23423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Fulle S, Protasi F, Di Tano G, Pietrangelo T, Beltramin A, Boncompagni S, Vecchiet L, Fano G. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. 2004;39:17–24. doi: 10.1016/j.exger.2003.09.012. [DOI] [PubMed] [Google Scholar]
  38. Ghosh S, Lertwattanarak R, Lefort N, Molina-Carrion M, Joya-Galeana J, Bowen BP, de Garduno-Garcia JJ, Abdul-Ghani M, Richardson A, DeFronzo RA, Mandarino L, Van Remmen H, Musi N. Reduction in reactive oxygen species production by mitochondria from elderly subjects with normal and impaired glucose tolerance. Diabetes. 2011;60:2051–60. doi: 10.2337/db11-0121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gianni P, Jan KJ, Douglas MJ, Stuart PM, Tarnopolsky MA. Oxidative stress and the mitochondrial theory of aging in human skeletal muscle. Exp Gerontol. 2004;39:1391–400. doi: 10.1016/j.exger.2004.06.002. [DOI] [PubMed] [Google Scholar]
  40. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr. 2000;71:885–92. doi: 10.1093/ajcn/71.4.885. [DOI] [PubMed] [Google Scholar]
  41. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005;165:777–83. doi: 10.1001/archinte.165.7.777. [DOI] [PubMed] [Google Scholar]
  42. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61:1059–64. doi: 10.1093/gerona/61.10.1059. [DOI] [PubMed] [Google Scholar]
  43. Guarente L. Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med. 2011;364:2235–44. doi: 10.1056/NEJMra1100831. [DOI] [PubMed] [Google Scholar]
  44. Guillet C, Prod’homme M, Balage M, Gachon P, Giraudet C, Morin L, Grizard J, Boirie Y. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J. 2004;18:1586–7. doi: 10.1096/fj.03-1341fje. [DOI] [PubMed] [Google Scholar]
  45. Gurd BJ. Deacetylation of PGC-1alpha by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis. Appl Physiol Nutr Metab. 2011;36:589–97. doi: 10.1139/h11-070. [DOI] [PubMed] [Google Scholar]
  46. Gurd BJ, Yoshida Y, McFarlan JT, Holloway GP, Moyes CD, Heigenhauser GJ, Spriet L, Bonen A. Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2011;301:R67–75. doi: 10.1152/ajpregu.00417.2010. [DOI] [PubMed] [Google Scholar]
  47. Gurd BJ, Holloway GP, Yoshida Y, Bonen A. In mammalian muscle, SIRT3 is present in mitochondria and not in the nucleus; and SIRT3 is upregulated by chronic muscle contraction in an adenosine monophosphate-activated protein kinase-independent manner. Metabolism. 2012;61:733–41. doi: 10.1016/j.metabol.2011.09.016. [DOI] [PubMed] [Google Scholar]
  48. Harber MP, Gallagher PM, Creer AR, Minchev KM, Trappe SW. Single muscle fiber contractile properties during a competitive season in male runners. 2004;287:R1124–31. doi: 10.1152/ajpregu.00686.2003. [DOI] [PubMed] [Google Scholar]
  49. Harber MP, Crane JD, Dickinson JM, Jemiolo B, Raue U, Trappe TA, Trappe SW. Protein synthesis and the expression of growth-related genes are altered by running in human vastus lateralis and soleus muscles. Am J Physiol Regul Integr Comp Physiol. 2009a;296:R708–14. doi: 10.1152/ajpregu.90906.2008. [DOI] [PubMed] [Google Scholar]
  50. Harber MP, Konopka AR, Douglass MD, Minchev K, Kaminsky LA, Trappe TA, Trappe S. Aerobic exercise training improves whole muscle and single myofiber size and function in older women. Am J Physiol Regul Integr Comp Physiol. 2009b;297:R1452–9. doi: 10.1152/ajpregu.00354.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Harber MP, Konopka AR, Jemiolo B, Trappe SW, Trappe TA, Reidy PT. Muscle protein synthesis and gene expression during recovery from aerobic exercise in the fasted and fed states. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1254–62. doi: 10.1152/ajpregu.00348.2010. [DOI] [PubMed] [Google Scholar]
  52. Harber MP, Konopka AR, Undem MK, Hinkley JM, Minchev K, Kaminsky LA, Trappe TA, Trappe S. Aerobic exercise training induces skeletal muscle hypertrophy and age-dependent adaptations in myofiber function in young and older men. J Appl Physiol. 2012;113:1495–504. doi: 10.1152/japplphysiol.00786.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. 1972;20:145–7. doi: 10.1111/j.1532-5415.1972.tb00787.x. [DOI] [PubMed] [Google Scholar]
  54. Henderson GC, Dhatariya K, Ford GC, Klaus KA, Basu R, Rizza RA, Jensen MD, Khosla S, O’Brien P, Nair KS. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J. 2009;23:631–41. doi: 10.1096/fj.08-117200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem. 1967;242:2278–82. [PubMed] [Google Scholar]
  56. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol. 1984;56:831–8. doi: 10.1152/jappl.1984.56.4.831. [DOI] [PubMed] [Google Scholar]
  57. Hoppeler H, Howald H, Conley K, Lindstedt SL, Claassen H, Vock P, Weibel ER. Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol. 1985;59:320–7. doi: 10.1152/jappl.1985.59.2.320. [DOI] [PubMed] [Google Scholar]
  58. Houmard JA, Weidner ML, Gavigan KE, Tyndall GL, Hickey MS, Alshami A. Fiber type and citrate synthase activity in the human gastrocnemius and vastus lateralis with aging. J Appl Physiol. 1998;85:1337–41. doi: 10.1152/jappl.1998.85.4.1337. [DOI] [PubMed] [Google Scholar]
  59. Howald H, Hoppeler H, Claassen H, Mathieu O, Straub R. Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans. Pflugers Arch. 1985;403:369–76. doi: 10.1007/BF00589248. [DOI] [PubMed] [Google Scholar]
  60. Howard C, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R, Guralnik JM, Semba RD. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol. 2007;103:17–20. doi: 10.1152/japplphysiol.00133.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Jaleel A, Short KR, Asmann YW, Klaus KA, Morse DM, Ford GC, Nair KS. In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins. Am J Physiol Endocrinol Metab. 2008;295:E1255–68. doi: 10.1152/ajpendo.90586.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Joseph AM, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM, Aranda JM, Sandesara BD, Pahor M, Manini TM, Marzetti E, Leeuwenburgh C. The Impact of Aging on Mitochondrial Function and Biogenesis Pathways in Skeletal Muscle of Sedentary High- and Low-Functioning Elderly Individuals. Aging Cell. 2012 doi: 10.1111/j.1474-9726.2012.00844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Karakelides H, Irving BA, Short KR, O’Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 2010;59:89–97. doi: 10.2337/db09-0591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kent-Braun JA, Ng AV. Skeletal muscle oxidative capacity in young and older women and men. J Appl Physiol. 2000;89:1072–8. doi: 10.1152/jappl.2000.89.3.1072. [DOI] [PubMed] [Google Scholar]
  65. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17:41–52. doi: 10.1016/j.ccr.2009.11.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Kim JS, Cross JM, Bamman MM. Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab. 2005;288:E1110–9. doi: 10.1152/ajpendo.00464.2004. [DOI] [PubMed] [Google Scholar]
  67. Konopka AR, Douglass MD, Kaminsky LA, Jemiolo B, Trappe TA, Trappe S, Harber MP. Molecular adaptations to aerobic exercise training in skeletal muscle of older women. J Gerontol A Biol Sci Med Sci. 2010;65:1201–7. doi: 10.1093/gerona/glq109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Konopka AR, Trappe TA, Jemiolo B, Trappe SW, Harber MP. Myosin heavy chain plasticity in aging skeletal muscle with aerobic exercise training. J Gerontol A Biol Sci Med Sci. 2011;66:835–41. doi: 10.1093/gerona/glr088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kopsidas G, Kovalenko SA, Kelso JM, Linnane AW. An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle. Mutat Res. 1998;421:27–36. doi: 10.1016/s0027-5107(98)00150-x. [DOI] [PubMed] [Google Scholar]
  70. Kovalenko SA, Kopsidas G, Kelso JM, Linnane AW. Deltoid human muscle mtDNA is extensively rearranged in old age subjects. Biochem Biophys Res Commun. 1997;232:147–52. doi: 10.1006/bbrc.1997.6251. [DOI] [PubMed] [Google Scholar]
  71. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS. Endurance exercise as a countermeasure for aging. Diabetes. 2008;57:2933–42. doi: 10.2337/db08-0349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Lanza IR, Nair KS. Mitochondrial metabolic function assessed in vivo and in vitro. Curr Opin Clin Nutr Metab Care. 2010;13:511–7. doi: 10.1097/MCO.0b013e32833cc93d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Lanza IR, Bhagra S, Nair KS, Port JD. Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements. J Magn Reson Imaging. 2011;34:1143–50. doi: 10.1002/jmri.22733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Lanza IR, Zabielski P, Klaus KA, Morse DM, Heppelmann CJ, Bergen HR, 3rd, Dasari S, Walrand S, Short KR, Johnson ML, Robinson MM, Schimke JM, Jakaitis DR, Asmann YW, Sun Z, Nair KS. Chronic caloric restriction preserves mitochondrial function in senescence without increasing mitochondrial biogenesis. Cell Metab. 2012;16:777–88. doi: 10.1016/j.cmet.2012.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Larsen RG, Callahan DM, Foulis SA, Kent-Braun JA. Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior. Appl Physiol Nutr Metab. 2012;37:88–99. doi: 10.1139/h11-135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science. 1999;285:1390–3. doi: 10.1126/science.285.5432.1390. [DOI] [PubMed] [Google Scholar]
  77. Leeuwenburgh C, Fiebig R, Chandwaney R, Ji LL. Aging and exercise training in skeletal muscle: responses of glutathione and antioxidant enzyme systems. Am J Physiol. 1994;267:R439–45. doi: 10.1152/ajpregu.1994.267.2.R439. [DOI] [PubMed] [Google Scholar]
  78. Leick L, Wojtaszewski JF, Johansen ST, Kiilerich K, Comes G, Hellsten Y, Hidalgo J, Pilegaard H. PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab. 2008;294:E463–74. doi: 10.1152/ajpendo.00666.2007. [DOI] [PubMed] [Google Scholar]
  79. Leick L, Lyngby SS, Wojtaszewski JF, Pilegaard H. PGC-1alpha is required for training-induced prevention of age-associated decline in mitochondrial enzymes in mouse skeletal muscle. Exp Gerontol. 2010;45:336–42. doi: 10.1016/j.exger.2010.01.011. [DOI] [PubMed] [Google Scholar]
  80. Lexell J, Henriksson-Larsen K, Winblad B, Sjostrom M. Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve. 1983;6:588–95. doi: 10.1002/mus.880060809. [DOI] [PubMed] [Google Scholar]
  81. Lezza AM, Boffoli D, Scacco S, Cantatore P, Gadaleta MN. Correlation between mitochondrial DNA 4977-bp deletion and respiratory chain enzyme activities in aging human skeletal muscles. 1994;205:772–9. doi: 10.1006/bbrc.1994.2732. [DOI] [PubMed] [Google Scholar]
  82. Ling C, Poulsen P, Carlsson E, Ridderstrale M, Almgren P, Wojtaszewski J, Beck-Nielsen H, Groop L, Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J Clin Invest. 2004;114:1518–26. doi: 10.1172/JCI21889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Ling C, Poulsen P, Simonsson S, Ronn T, Holmkvist J, Almgren P, Hagert P, Nilsson E, Mabey AG, Nilsson P, Vaag A, Groop L. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest. 2007;117:3427–35. doi: 10.1172/JCI30938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Louis E, Raue U, Yang Y, Jemiolo B, Trappe S. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol. 2007;103:1744–51. doi: 10.1152/japplphysiol.00679.2007. [DOI] [PubMed] [Google Scholar]
  85. Mai S, Muster B, Bereiter-Hahn J, Jendrach M. Autophagy proteins LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage and influence lifespan. Autophagy. 2012;8:47–62. doi: 10.4161/auto.8.1.18174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M. Autophagy is required to maintain muscle mass. Cell Metab. 2009;10:507–15. doi: 10.1016/j.cmet.2009.10.008. [DOI] [PubMed] [Google Scholar]
  87. Matsushima Y, Goto Y, Kaguni LS. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM) Proc Natl Acad Sci U S A. 2010;107:18410–5. doi: 10.1073/pnas.1008924107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. McGee SL, Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes. 2004;53:1208–14. doi: 10.2337/diabetes.53.5.1208. [DOI] [PubMed] [Google Scholar]
  89. McGee SL, Fairlie E, Garnham AP, Hargreaves M. Exercise-induced histone modifications in human skeletal muscle. J Physiol. 2009;587:5951–8. doi: 10.1113/jphysiol.2009.181065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Moore AZ, Biggs ML, Matteini A, O’Connor A, McGuire S, Beamer BA, Fallin MD, Fried LP, Walston J, Chakravarti A, Arking DE. Polymorphisms in the mitochondrial DNA control region and frailty in older adults. PLoS One. 2010;5:e11069. doi: 10.1371/journal.pone.0011069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12:403–9. doi: 10.1016/j.jamda.2011.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51:1602–9. doi: 10.1046/j.1532-5415.2003.51534.x. [DOI] [PubMed] [Google Scholar]
  93. Pandorf CE, Haddad F, Wright C, Bodell PW, Baldwin KM. Differential epigenetic modifications of histones at the myosin heavy chain genes in fast and slow skeletal muscle fibers and in response to muscle unloading. Am J Physiol Cell Physiol. 2009;297:C6–16. doi: 10.1152/ajpcell.00075.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Pansarasa O, Castagna L, Colombi B, Vecchiet J, Felzani G, Marzatico F. Age and sex differences in human skeletal muscle: role of reactive oxygen species. Free Radic Res. 2000;33:287–93. doi: 10.1080/10715760000301451. [DOI] [PubMed] [Google Scholar]
  95. Pasiakos SM, McClung HL, McClung JP, Urso ML, Pikosky MA, Cloutier GJ, Fielding RA, Young AJ. Molecular responses to moderate endurance exercise in skeletal muscle. Int J Sport Nutr Exerc Metab. 2010;20:282–90. doi: 10.1123/ijsnem.20.4.282. [DOI] [PubMed] [Google Scholar]
  96. Perry CG, Kane DA, Lanza IR, Neufer PD. Methods for assessing mitochondrial function in diabetes. Diabetes. 2013;62:1041–53. doi: 10.2337/db12-1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140–2. doi: 10.1126/science.1082889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Picard M, Ritchie D, Wright KJ, Romestaing C, Thomas MM, Rowan SL, Taivassalo T, Hepple RT. Mitochondrial functional impairment with aging is exaggerated in isolated mitochondria compared to permeabilized myofibers. Aging Cell. 2010;9:1032–46. doi: 10.1111/j.1474-9726.2010.00628.x. [DOI] [PubMed] [Google Scholar]
  99. Picard M, Taivassalo T, Ritchie D, Wright KJ, Thomas MM, Romestaing C, Hepple RT. Mitochondrial structure and function are disrupted by standard isolation methods. PLoS One. 2011;6:e18317. doi: 10.1371/journal.pone.0018317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Picca A, Fracasso F, Pesce V, Cantatore P, Joseph AM, Leeuwenburgh C, Gadaleta MN, Lezza AM. Age- and calorie restriction-related changes in rat brain mitochondrial DNA and TFAM binding. Age (Dordr) 2012 doi: 10.1007/s11357-012-9465-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Proctor DN, Sinning WE, Walro JM, Sieck GC, Lemon PW. Oxidative capacity of human muscle fiber types: effects of age and training status. J Appl Physiol. 1995;78:2033–8. doi: 10.1152/jappl.1995.78.6.2033. [DOI] [PubMed] [Google Scholar]
  102. Rasmussen UF, Krustrup P, Kjaer M, Rasmussen HN. Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria. Exp Gerontol. 2003a;38:877–86. doi: 10.1016/s0531-5565(03)00092-5. [DOI] [PubMed] [Google Scholar]
  103. Rasmussen UF, Krustrup P, Kjaer M, Rasmussen HN. Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch. 2003b;446:270–8. doi: 10.1007/s00424-003-1022-2. [DOI] [PubMed] [Google Scholar]
  104. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci. 2007;62:1407–12. doi: 10.1093/gerona/62.12.1407. [DOI] [PubMed] [Google Scholar]
  105. Robinson MM, Hamilton KL, Miller BF. The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise. J Appl Physiol. 2009;107:8–16. doi: 10.1152/japplphysiol.00343.2009. [DOI] [PubMed] [Google Scholar]
  106. Ronn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P, Tuomi T, Isomaa B, Groop L, Vaag A, Ling C. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia. 2008;51:1159–68. doi: 10.1007/s00125-008-1018-8. [DOI] [PubMed] [Google Scholar]
  107. Rooyackers OE, Adey DB, Ades PA, Nair KS. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci U S A. 1996;93:15364–9. doi: 10.1073/pnas.93.26.15364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Rosenberg I. Summary Comments: epidemiological and methodological problems in determinig nutritional status of older persons. Am J Clin Nutr. 1989;50:1231–3. [Google Scholar]
  109. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S–991S. doi: 10.1093/jn/127.5.990S. [DOI] [PubMed] [Google Scholar]
  110. Rossi P, Marzani B, Giardina S, Negro M, Marzatico F. Human skeletal muscle aging and the oxidative system: cellular events. Curr Aging Sci. 2008;1:182–91. doi: 10.2174/1874609810801030182. [DOI] [PubMed] [Google Scholar]
  111. Roth SM, Martel GF, Ferrell RE, Metter EJ, Hurley BF, Rogers MA. Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood) 2003;228:706–9. doi: 10.1177/153537020322800609. [DOI] [PubMed] [Google Scholar]
  112. Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM. A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell. 2012;151:1319–31. doi: 10.1016/j.cell.2012.10.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Ryan AS, Ivey FM, Prior S, Li G, Hafer-Macko C. Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors. Stroke. 2011;42:416–20. doi: 10.1161/STROKEAHA.110.602441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Safdar A, Hamadeh MJ, Kaczor JJ, Raha S, Debeer J, Tarnopolsky MA. Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One. 2010;5:e10778. doi: 10.1371/journal.pone.0010778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Safdar A, Little JP, Stokl AJ, Hettinga BP, Akhtar M, Tarnopolsky MA. Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J Biol Chem. 2011;286:10605–17. doi: 10.1074/jbc.M110.211466. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  116. Semba RD, Ferrucci L, Sun K, Walston J, Varadhan R, Guralnik JM, Fried LP. Oxidative stress and severe walking disability among older women. Am J Med. 2007a;120:1084–9. doi: 10.1016/j.amjmed.2007.07.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Semba RD, Ferrucci L, Sun K, Walston J, Varadhan R, Guralnik JM, Fried LP. Oxidative stress is associated with greater mortality in older women living in the community. J Am Geriatr Soc. 2007b;55:1421–5. doi: 10.1111/j.1532-5415.2007.01308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C. New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci. 2010;123:2533–42. doi: 10.1242/jcs.070490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, Nair KS. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003;52:1888–96. doi: 10.2337/diabetes.52.8.1888. [DOI] [PubMed] [Google Scholar]
  120. Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab. 2004;286:E92–101. doi: 10.1152/ajpendo.00366.2003. [DOI] [PubMed] [Google Scholar]
  121. Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, Nair KS. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A. 2005a;102:5618–23. doi: 10.1073/pnas.0501559102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Short KR, Vittone JL, Bigelow ML, Proctor DN, Coenen-Schimke JM, Rys P, Nair KS. Changes in myosin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training. J Appl Physiol. 2005b;99:95–102. doi: 10.1152/japplphysiol.00129.2005. [DOI] [PubMed] [Google Scholar]
  123. Slivka DR, Dumke CL, Tucker TJ, Cuddy JS, Ruby B. Human mRNA response to exercise and temperature. Int J Sports Med. 2012;33:94–100. doi: 10.1055/s-0031-1287799. [DOI] [PubMed] [Google Scholar]
  124. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010;143:802–12. doi: 10.1016/j.cell.2010.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Tonkonogi M, Fernstrom M, Walsh B, Ji LL, Rooyackers O, Hammarqvist F, Wernerman J, Sahlin K. Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans. Pflugers Arch. 2003;446:261–9. doi: 10.1007/s00424-003-1044-9. [DOI] [PubMed] [Google Scholar]
  126. Trappe S, Godard M, Gallagher P, Carroll C, Rowden G, Porter D. Resistance training improves single muscle fiber contractile function in older women. 2001;281:C398–406. doi: 10.1152/ajpcell.2001.281.2.C398. [DOI] [PubMed] [Google Scholar]
  127. Trappe S, Gallagher P, Harber M, Carrithers J, Fluckey J, Trappe T. Single muscle fibre contractile properties in young and old men and women. J Physiol. 2003;552:47–58. doi: 10.1113/jphysiol.2003.044966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Trappe S, Hayes E, Galpin AJ, Kaminsky LA, Jemiolo B, Fink WJ, Trappe TA, Jansson A, Gustafsson T, Tesch PA. New Records In Aerobic Power Among Octogenarian Lifelong Endurance Athletes. J Appl Physiol. 2012 doi: 10.1152/japplphysiol.01107.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Trappe T, Williams R, Carrithers J, Raue U, Esmarck B, Kjaer M, Hickner R. Influence of age and resistance exercise on human skeletal muscle proteolysis: a microdialysis approach. J Physiol. 2004;554:803–13. doi: 10.1113/jphysiol.2003.051755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet. 1989;1:637–9. doi: 10.1016/s0140-6736(89)92143-0. [DOI] [PubMed] [Google Scholar]
  131. von Walden F, Jakobsson F, Edstrom L, Nader GA. Altered autophagy gene expression and persistent atrophy suggest impaired remodeling in chronic hemiplegic human skeletal muscle. Muscle Nerve. 2012;46:785–92. doi: 10.1002/mus.23387. [DOI] [PubMed] [Google Scholar]
  132. Waters DL, Mullins PG, Qualls CR, Raj DS, Gasparovic C, Baumgartner RN. Mitochondrial function in physically active elders with sarcopenia. Mech Ageing Dev. 2009;130:315–9. doi: 10.1016/j.mad.2009.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A. 2009;106:20405–10. doi: 10.1073/pnas.0911570106. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  134. Wenz T. Mitochondria and PGC-1alpha in Aging and Age-Associated Diseases. J Aging Res. 2011;2011:810619. doi: 10.4061/2011/810619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Westphal CH, Dipp MA, Guarente L. A therapeutic role for sirtuins in diseases of aging? Trends Biochem Sci. 2007;32:555–60. doi: 10.1016/j.tibs.2007.09.008. [DOI] [PubMed] [Google Scholar]
  136. White AT, Schenk S. NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise. Am J Physiol Endocrinol Metab. 2012;303:E308–21. doi: 10.1152/ajpendo.00054.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Wilkinson SB, Phillips SM, Atherton PJ, Patel R, Yarasheski KE, Tarnopolsky MA, Rennie MJ. Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. J Physiol. 2008;586:3701–17. doi: 10.1113/jphysiol.2008.153916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Williamson DL, Raue U, Slivka DR, Trappe S. Resistance exercise, skeletal muscle FOXO3A, and 85-year-old women. J Gerontol A Biol Sci Med Sci. 2010;65:335–43. doi: 10.1093/gerona/glq005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Wright DC, Han DH, Garcia-Roves PM, Geiger PC, Jones TE, Holloszy JO. Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem. 2007;282:194–9. doi: 10.1074/jbc.M606116200. [DOI] [PubMed] [Google Scholar]
  140. Zhang C, Cuervo AM. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med. 2008;14:959–65. doi: 10.1038/nm.1851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Zucchini C, Pugnaloni A, Pallotti F, Solmi R, Crimi M, Castaldini C, Biagini G, Lenaz G. Human skeletal muscle mitochondria in aging: lack of detectable morphological and enzymic defects. Biochem Mol Biol Int. 1995;37:607–16. [PubMed] [Google Scholar]
  142. Zwetsloot KA, Laye MJ, Booth FW. Novel epigenetic regulation of skeletal muscle myosin heavy chain genes. Focus on “Differential epigenetic modifications of histones at the myosin heavy chain genes in fast and slow skeletal muscle fibers and in response to muscle unloading”. Am J Physiol Cell Physiol. 2009;297:C1–3. doi: 10.1152/ajpcell.00176.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES